The Future Science Group has published it’s new type of article recently. It is aimed at helping medical patients understand things better and more clearly. The Plain Language Summaries are a way of presenting information in simple terms so that patients and people who are not of an advanced medical background will understand the research. This new type of article presents findings to help patients make better decisions as well. It is important for them to understand their options. Plain Language Summaries are a way for patients to easily become informed about the various topics and research findings in the medical field. This type of article is thought to be a very new and innovative way to present information to help people. This new type of article will be published in the Future Science Group’s journals. They currently have 35 different peer-reviewed journals. The first Plain Language Summary is titled “ENLIVEN study: pexidartinib for tenosynovial giant cell tumor (TGCT),” it focuses on a clinical trial that was previously published in another peer-reviewed medical journal called The Lancet. The article was written by Dr. William Tap. It focuses on medication for patients with TGCT. The Future Science Group hopes to make findings like these more accessible and easier to understand through the publication of their new type of article, the Plain Language Summaries. They also hope to advance the sharing of medical information, clinical practice, and research to new horizons. By focusing on patients and putting them first, the Future Science Group will be able to achieve this.